A secondary analysis of cortical atrophy and plasma amyloid β patterns in older patients with cognitive frailty undergoing elective surgery
Authors:
- Rudolf MörgeliRMRudolf Mörgeli
- Friedrich BorchersFBFriedrich Borchers
- Insa FeinkohlIFInsa Feinkohl
- Sophie K. PiperSPSophie K. Piper
- Tobias PischonTPTobias Pischon
- Arjen J.C. SlooterASArjen J.C. Slooter
- Claudia SpiesCSClaudia Spies
- Janine WiebachJWJanine Wiebach
- Georg WintererGWGeorg Winterer
- Norman ZachariasNZNorman Zacharias
- Florian Lammers-LietzFLFlorian Lammers-Lietz
Open Access
- 2 July 2025
- journal article
- research article
- Published by Springer Nature in BMC Geriatrics
- Vol. 25 (1) , 1-16
Abstract
Background: The etiology of cognitive impairment in frailty may be related to age or to an independent neurodegenerative process, such as Alzheimer’s disease (AD). In this secondary analysis, we examine cognitive frailty in patients aged 65 and older undergoing elective surgery, and explore associations with aging- and AD-related cortical atrophy patterns and amyloid β (Aβ) concentrations. Methods: Cognitive frailty (CF) was defined as the co-occurrence of (pre-)frailty and cognitive impairment (CI). Cognitive performance was assessed using the MMSE and the Cambridge Neuropsychological Teste Automated Battery (CANTAB), while frailty was assessed with a modified version of Fried’s frailty phenotype. Aging- and AD-related cortical atrophy patterns were derived from T1-weighted MRI using Freesurfer software. MRI patterns and plasma concentrations of Aβ species 40 and 42 (including Aβ 42/40 ratio) were compared to physically robust, cognitively unimpaired patients using multiple regression analyses and presented as regression coefficient b with 95% confidence intervals. Results: MRI data of N = 489 patients (N = 251 with frailty, N = 15 with CI, N = 43 with CF) and plasma Aβ concentrations of N = 786 patients (N = 400 with frailty, N = 20 with CI, N = 101 with CF) were analyzed. Cognitive frailty was associated with both aging-related and AD-related MRI signatures (bage=-0.070 [-0.113; -0.028], bAD=-0.069 [-0.118; -0.020]). Amyloid β42 was significantly lower in frail patients (b=-0.14 [-0.29; -0.01]), while β42/β40-ratio was lower in patients with frailty (b=-0.11 [-0.21; -0.01]) and cognitive frailty (b=-0.015 [-0.28; -0.03]). Conclusion: Our results suggest that atrophy in aging- and AD-related cortical regions is associated with cognitive frailty. Plasma amyloid β42/β40-ratios were significantly lower in patients with frailty and cognitive frailty, suggesting that (pre-)frailty in general, rather than cognitive frailty specifically, is associated with AD-like changes. Hence, AD-related pathology seems to be associated with cognitive frailty, but the available data is not sufficient to indicate shared pathomechanisms between AD and cognitive frailty. Trial Registration: ClinicalTrials.gov. Identifier NCT02265263, Date October 15th, 2014.Keywords
Funding Information
- Charité - Universitätsmedizin Berlin
This publication has 56 references indexed in Scilit:
- Effects of three kinds of anti-amyloid-β drugs on clinical, biomarker, neuroimaging outcomes and safety indexes: A systematic review and meta-analysis of phase II/III clinical trials in Alzheimer’s diseaseAgeing Research Reviews, 2023
- Generalized Linear Mixed Models with Applications in Agriculture and Biology2023
- Prevalence of multidimensional frailty and pre-frailty in older people in different settings: A systematic review and meta-analysisAgeing Research Reviews, 2021
- Dexmedetomidine Restores Autophagic Flux, Modulates Associated microRNAs and the Cholinergic Anti-inflammatory Pathway upon LPS-Treatment in RatsJournal of Neuroimmune Pharmacology, 2021
- The impact of age and frailty on skeletal muscle autophagy markers and specific strength: A cross-sectional comparisonExperimental Gerontology, 2019
- Personalized risk prediction of postoperative cognitive impairment – rationale for the EU-funded BioCog projectEuropean Psychiatry, 2018
- The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairmentAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2018
- Is the Alzheimer’s disease cortical thickness signature a biological marker for memory?Brain Imaging and Behavior, 2015
- Cognitive frailty: What is still missing?The Journal of nutrition, health and aging, 2015
- Cognitive frailty: Rational and definition from an (I.A.N.A./I.A.G.G.) International Consensus GroupThe Journal of nutrition, health and aging, 2013